文献速递消化、代谢与肾脏急症重症综合管理与镇静镇痛

老年人院前阿片类药物剂量的下游效应:一项回顾性队列研究

The Downstream Effects of Prehospital Opioid Dosing in Older Adults: A Retrospective Cohort Study.
PubMed 文献 · Acad Emerg Med · 2026-01-01
一句话结论老年人院前接受高剂量阿片类药物与急诊/住院期间反应性改变和谵妄风险增加相关,但缺氧、30天死亡和急诊停留时间无差异。

本研究为回顾性队列研究,纳入2019至2024年间某医疗系统附属急救机构中≥65岁且接受阿片类药物的成人患者,排除已建立高级气道及无体重记录者。按最大单次和累计体重剂量分为低、治疗、高剂量组,采用泊松回归调整年龄、性别、生命体征、格拉斯哥昏迷评分、急诊严重指数和主诉后比较急诊/住院结局。高单次剂量组(排除合用镇静剂者)反应性改变风险aRR=1.28(95%CI 1.03-1.58),谵妄风险aRR=2.43(95%CI 1.08-5.45);纳入合用镇静剂者后结果相似。缺氧、30天死亡和急诊停留时间在各剂量组间无差异。

要点

  • 老年人院前高单次阿片剂量与急诊/住院反应性改变风险增加相关(aRR=1.28,95%CI 1.03-1.58,排除合用镇静剂者)。
  • 老年人院前高单次阿片剂量与谵妄风险增加相关(aRR=2.43,95%CI 1.08-5.45,排除合用镇静剂者)。
  • 纳入311例(4.9%)合用镇静剂者后,高剂量组反应性改变aRR=1.28(95%CI 1.06-1.56),谵妄RR=2.65(95%CI 1.25-5.59)。
  • 缺氧、30天内死亡和急诊停留时间在高剂量与低/治疗剂量组间无差异。
  • 院前急救用药可能影响老年患者后续急诊和住院病程。

适用人群与场景

  • 年龄≥65岁、在2019至2024年间由医疗系统附属急救机构给予阿片类药物的成人患者。
  • 排除已建立高级气道和无体重记录的患者。

诊断标准与关键阈值

  • 按最大单次和累计体重剂量将阿片类药物剂量分为低、治疗或高剂量。

研究设计与关键结果

  • 回顾性队列研究,共纳入6406例患者,其中高剂量747例(11.7%,95%CI 10.9-12.5),治疗剂量3663例(57.2%,95%CI 56.0-58.4),低剂量1996例(31.2%,95%CI 30.0-32.3)。
  • 高最大单次剂量 vs 低/治疗剂量(排除合用镇静剂者)与急诊/住院反应性改变风险增加相关(aRR=1.28,95%CI 1.03-1.58)和谵妄风险增加相关(aRR=2.43,95%CI 1.08-5.45)。
  • 纳入311例(4.9%)合用镇静剂者后,高剂量组 vs 低/治疗剂量组反应性改变aRR=1.28(95%CI 1.06-1.56),谵妄RR=2.65(95%CI 1.25-5.59)。
  • 缺氧、30天内死亡和急诊停留时间在剂量组间无差异。

证据类型、等级与局限

  • 证据类型:回顾性队列研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,老年人院前给予高阿片剂量与反应性改变和谵妄发生率增加相关,院前急救可能影响患者急诊和住院病程。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Older adults experience age-related physiological changes that alter the pharmacokinetics and pharmacodynamics of certain medications, which may necessitate reduced dosing. Our objective was to assess emergency department (ED) and hospital outcomes of older patients administered opioids by emergency medical services (EMS) clinicians.

METHODS: Retrospective cohort study of adults ≥ 65 years who received an opioid between 2019 and 2024 within a health system-affiliated EMS agency. We excluded patients with an advanced airway and those with no documented weight. Maximum single and cumulative weight-based opioid dosages were classified as low, therapeutic, or high. Outcomes were measured in the ED/hospital and compared using Poisson regression with Huber/White standard errors, adjusted for age, sex, vitals, Glascow Coma Scale, emergency severity index, and chief concern. Results were reported as adjusted risk ratios (aRRs).

RESULTS: A total of 6406 patients, including 747 (11.7%, 95% CI: 10.9-12.5) with a high opioid dose, 3663 (57.2%, 95% CI: 56.0-58.4) with a therapeutic dose, and 1996 (31.2%, 95% CI: 30.0-32.3) with a low dose, were included. Receipt of a high maximum single opioid dose versus a low/therapeutic dose (excluding patients receiving a concomitant sedative) was associated with increased risk of altered responsiveness (aRR = 1.28, 95% CI: 1.03-1.58) and delirium (aRR = 2.43, 95% CI: 1.08-5.45) in the ED/hospital setting. When 311 (4.9%) patients who received a concomitant sedative were included, patients who received a high opioid dose similarly had an increased risk of altered responsiveness (aRR = 1.28, 95% CI: 1.06-1.56) and delirium (RR = 2.65, 95% CI: 1.25-5.59), compared to a low/therapeutic dose. There was no difference in outcomes of hypoxia, death within 30 days, or ED length of stay between dose groups.

CONCLUSION: Prehospital administration of high opioid doses to older patients was associated with increased rates of altered responsiveness and delirium. These findings highlight how out-of-hospital care can impact a patient's ED and hospital course.

来源:Acad Emerg Med,查看原文。版权归原作者所有。

参考来源

  1. McGuire SS, Brown CS, Palmer AK, et al. The Downstream Effects of Prehospital Opioid Dosing in Older Adults: A Retrospective Cohort Study. Acad Emerg Med. 2026. PMID: 42023551. doi:10.1111/acem.70294

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。